Basel, Switzerland (AHN) - A new round of tests for Novartis’ cell culture-based H1N1 vaccine carried out by the University of Leicester in the United Kingdom showed the shot was easily tolerated by adults and many healthy patients may only need one dose per season. According to Novartis, “the...